EQUILLIUM INC
EQ · NASDAQ
Updated at 2026-10-13 15:06:24
- Today's High
- $1.51
- Today’s Low
- $1.43
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $1.42
- Previous Close
- $1.50
- Volume
- 383.74K
- Market Cap
- $95.11M
- P/E Ratio
- --
- EPS
- $-0.32
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 2223 AVENIDA DE LA PLAYA, LA JOLLA, CA, UNITED STATES, 92037
- Country
- US
- Listing Date
- 2018-10-12
- Fiscal Year End
- December
- Shares Outstanding
- 63.23M
- CIK
- 0001746466
Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory or immuno-inflammatory disorders with unmet medical needs. The company is headquartered in La Jolla, California.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$5.15M
2026-03-31
$5.58M
2025-12-31
$3.93M
2025-09-30
$4.57M
Net Income
2026-06-30
-$4.69M
2026-03-31
-$5.31M
2025-12-31
-$3.77M
2025-09-30
-$4.23M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.04
2026-03-31
$-0.06
2025-12-31
$-0.04
2025-09-30
$-0.06
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$5.08M
2026-03-31
-$5.28M
2025-12-31
-$3.75M
2025-09-30
-$4.2M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $5.15M | $5.58M | $3.93M | $4.57M |
| Net Income | -$4.69M | -$5.31M | -$3.77M | -$4.23M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.04 | $-0.06 | $-0.04 | $-0.06 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$5.08M | -$5.28M | -$3.75M | -$4.2M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.